The 65 rating InvestorsObserver gives to Cyclo Therapeutics Inc (CYTH) stock puts it near the top of the Drug Manufacturers - Specialty & Generic industry. In addition to scoring higher than 89 percent of stocks in the Drug Manufacturers - Specialty & Generic industry, CYTH’s 65 overall rating means the stock scores better than 65 percent of all stocks.
CYTH has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on CYTH!